Ontology highlight
ABSTRACT:
SUBMITTER: Tian S
PROVIDER: S-EPMC5165228 | biostudies-literature | 2016
REPOSITORIES: biostudies-literature
Tian Suyan S Chang Howard H HH Orange Dana D Gu Jingkai J Suárez-Fariñas Mayte M
Computational and mathematical methods in medicine 20161205
In order to test if two chemically or pharmaceutically equivalent products have the same efficacy and/or toxicity, a bioequivalence (BE) study is conducted. The 80%/125% rule is the most commonly used criteria for BE and states that BE cannot be claimed unless the 90% CIs for the ratio of selected pharmacokinetics (PK) parameters of the tested to the reference drug are within 0.8 to 1.25. Considering that estimates of these PK parameters are derived from the concentration-versus-time curves, a d ...[more]